US equities |
NVDA $181.60 ▼-9.26% MU $656.39 ▼-17.46% AMD $404.40 ▼-17.26% TSLA $343.69 ▼-10.77% AAPL $344.17 ▼-1.53% SNDK $806.43 ▼-22.26% MSFT $535.93 ▼-3.58% AMZN $260.21 ▼-2.19%
FinancialContent

Neuronetics, Inc. - Common Stock (NQ:STIM)

2.430 -0.275 (-10.17%)
Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Neuronetics Q3 Earnings Call Highlights ↗
Neuronetics (NASDAQ:STIM) reported third-quarter 2026 revenue growth, wider gross margin and a return to positive adjusted EBITDA, citing record NeuroStar system sales and continued revenue-cycle... 
Via MarketBeat
Topics Earnings
News headline image
Neuronetics (STIM) Q3 2026 Earnings Call Transcript ↗
Clinic growth carried the quarter, while a shift in revenue mix raised new questions. 
Via The Motley Fool
Topics Earnings
Premarket Movers Nov. 4, 2026: Gainers and Losers ↗
Via Chartmill
News headline image
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
First-of-Its-Kind Integration Connects TrakStar and AdvancedMD, Delivering TMS Care Across Clinical, Operational, and Billing Workflows 
From Neuronetics; AdvancedMD
Via GlobeNewswire
Neuronetics Inc (NASDAQ:STIM) Posts Narrower Loss in Q1 2026, Pre-Market Rises Despite Revenue Miss ↗
Via Chartmill
NEURONETICS INC (NASDAQ:STIM) Reports Q4 Revenue Beat but Shares Drop on Cautious Outlook ↗
Via Chartmill
News headline image
Neuronetics (STIM) Q2 2026 Earnings Call Transcript ↗
Greenbrook revenue surged 16.8% while NeuroStar transitions to new commercial models. 
Via The Motley Fool
Topics Earnings
What's going on in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release,... 
Via Benzinga
Here are the top movers in Tuesday's session. ↗
Via Chartmill
News headline image
Neuronetics Q2 Earnings Call Highlights ↗
Neuronetics (NASDAQ:STIM) reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic business expanded and the company introduced... 
Via MarketBeat
Topics Artificial Intelligence Earnings
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery 
From Neuronetics
Via GlobeNewswire
Which stocks are moving on Monday? ↗
Via Chartmill
Unusual volume stocks in Monday's session ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-07-20: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment... 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics (STIM) Q1 2026 Earnings Transcript ↗
Neuronetics (STIM) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
Policy Update Broadens Access to Innovative, Non-Drug Depression Treatment Across 26 States and Washington, D.C. 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics (STIM) Q4 2025 Earnings Transcript ↗
Neuronetics (STIM) Q4 2025 Earnings Transcript 
Via The Motley Fool
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
 
Via Benzinga
News headline image
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
New Policy Update Brings Innovative, Non-Drug Depression Treatment to Adolescents Across 26 States 
From Neuronetics
Via GlobeNewswire
News headline image
Tuesday's pre-market session: top gainers and losers ↗
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >